180 Life Sciences Files 2024 Annual Report
Ticker: FRMM · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 10-K |
| Filed Date | Mar 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 10-k, pharmaceuticals
TL;DR
180 Life Sciences filed its 2024 10-K. All systems go (for now).
AI Summary
180 Life Sciences Corp. filed its annual 10-K report for the fiscal year ending December 31, 2024. The company, formerly known as KBL Merger Corp. IV, is incorporated in Delaware and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Palo Alto, California.
Why It Matters
This filing provides a comprehensive overview of 180 Life Sciences Corp.'s financial performance and business operations for the fiscal year 2024, crucial for investors and stakeholders to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing with no immediate red flags or significant new information presented in the provided snippet.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- KBL Merger Corp. IV (company) — Former company name
- December 31, 2024 (date) — Fiscal year end
- Palo Alto, CA (location) — Principal executive offices
FAQ
What is the primary business of 180 Life Sciences Corp.?
180 Life Sciences Corp. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
When did 180 Life Sciences Corp. change its name?
The company's former name was KBL Merger Corp. IV, and the date of the name change was November 15, 2016.
Where are 180 Life Sciences Corp.'s principal executive offices located?
The principal executive offices of 180 Life Sciences Corp. are located at 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
What is the Commission File Number for 180 Life Sciences Corp.?
The Commission File Number for 180 Life Sciences Corp. is 001-38105.
What type of filing is this document?
This document is a Form 10-K, which is an annual report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding 180 Life Sciences Corp. (FRMM).